Discover why Marvel Cinematic Universe's Phase 3 stands out as the pinnacle of storytelling, cultural impact, and overall quality in this in-depth exploration.

Shares of Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) fell 13% on Wednesday following the announcement that its Phase 3 COMPASS ...

Three years on from a splashy unveiling, Areteia Therapeutics has reported a phase 3 victory that could boost its bid to launch an oral rival to the biologics that dominate a multibillion-dollar ...

Regeneron is racing to regulators after reporting a phase 3 win in an ultrarare disease. | Regeneron is racing to regulators after reporting a phase 3 win in an ultrarare disease. The biotech plans to ...

Pfizer will acquire Metsera in a deal worth $4.9 billion up front and up to $7.3 billion if the acquired assets succeed ...

Upadacitinib demonstrated significant efficacy in promoting scalp hair regrowth in severe alopecia areata patients, achieving primary endpoints in nearly half of the participants. The phase 3 trials ...

Completed patient enrollment within nine months with nearly half enrolled from the U.S.Expect to report Phase 3 topline data ...

Palvella’s QTORIN rapamycin is its main value driver. Read why PVLA could pay off for patient long-term investors betting on ...

Itepekimab, an investigational monoclonal antibody for chronic obstructive pulmonary disease (COPD), demonstrated mixed results in a pair of phase 3 studies evaluating the treatment in former smokers ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) ...

Ambitious MMORPG Ashes of Creation is gearing up for the next stage of its ongoing alpha test, and there's a lot to look forward to. In a new development livestream, Intrepid Studios reveals a big ...